Molecular Pharmaceutics
IF
4.32
Papers
4914
Papers 5270
1 page of 527 pages (5,270 results)
Newest
#1Hongzhi Wang (OSU: Ohio State University)
#2Peixuan Guo (OSU: Ohio State University)
Therapeutic efficiency and toxicity are two of the three critical factors in molecular therapy and pharmaceutical drug development. Specific tumor targeting and rapid renal excretion contribute to improving efficiency and reducing toxicity. We recently found that RNA nanoparticles display rubber-like properties, enabling them to deliver therapeutics to cancer with high efficiency. Off-target RNA nanoparticles were rapidly cleared by renal excretion, resulting in nontoxicity. However, previous bi...
Source
#1Qianqian Jiang (Anhui University of Chinese Medicine)H-Index: 1
#2Mengmeng Zhang (Anhui University of Chinese Medicine)H-Index: 1
Last. Ye Yang (Anhui University of Chinese Medicine)H-Index: 1
view all 0 authors...
Breast cancer is one of the most common malignant tumors in women. The existence of multiple breast cancer subtypes often leads to chemotherapy failure or the development of drug resistance. In recent years, photodynamic therapy has been proven to enhance the sensitivity of tumors to chemotherapeutic drugs. Porphyrin-based metal-organic framework (MOF) materials could simultaneously be used as carriers for chemotherapy and photosensitizers in photodynamic therapy. In this paper, doxorubicin hydr...
Source
#1Lingling Xu (HUST: Huazhong University of Science and Technology)H-Index: 1
#2Yihan Chen (HUST: Huazhong University of Science and Technology)H-Index: 9
Last. Luyang Yi (HUST: Huazhong University of Science and Technology)H-Index: 1
view all 0 authors...
Early diagnosis of myocardial ischaemia-reperfusion (MI/R) injury is important for protecting the myocardium and improving patient prognoses. Fortunately, the platelet membrane possesses the ability to target the region of MI/R injury. Therefore, we hypothesized that platelet membrane-coated particles (PMPs) could be used to detect early MI/R injury by ultrasound imaging. We designed PMPs with a porous polylactic-co-glycolic acid (PLGA) core coated with a platelet membrane shell. Red blood cell ...
Source
#1Marta Glinka (GUT: Gdańsk University of Technology)H-Index: 3
#2Katerina Filatova (Tomas Bata University in Zlín)H-Index: 1
Last. Vladimír Sedlařík (Tomas Bata University in Zlín)H-Index: 11
view all 0 authors...
The aim of this study was to fabricate novel microparticles (MPs) for efficient and long-term delivery of amikacin (AMI). The emulsification method proposed for encapsulating AMI employed low-molecular-weight poly(lactic acid) (PLA) and poly(lactic acid-co-polyethylene glycol) (PLA-PEG), both supplemented with poly(vinyl alcohol) (PVA). The diameters of the particles obtained were determined as less than 30 μm. Based on an in-vitro release study, it was proven that the MPs (both PLA/PVA- and PLA...
Source
#1David A Murphy (A&M: Texas A&M University)
#2Heyong Cheng (A&M: Texas A&M University)H-Index: 4
Last. Isaac M Adjei (A&M: Texas A&M University)
view all 0 authors...
The adoptive transfer of natural killer (NK) cells, which can recognize and obliterate cancer cells, provides a practical alternative to current treatment modalities to improve cancer patients' survival. However, translating NK cell therapies to treat solid tumors has proven challenging due to the tumor microenvironment (TME). Hypoxia in the TME induces immunosuppression that inhibits the cytotoxic function of NK cells. Thus, reversing hypoxia-induced immunosuppression is critical for effective ...
Source
#1Chen-Yan Zhang (NPU: Northwestern Polytechnical University)H-Index: 13
#2Chang-Qing Yang (NPU: Northwestern Polytechnical University)H-Index: 2
Last. Li-Heng Luo (NPU: Northwestern Polytechnical University)
view all 0 authors...
Muscle atrophy usually occurs under mechanical unloading, which increases the risk of injury to reduce the functionality of the moving system, while there is still no effective therapy until now. It was found that miR-194 was significantly downregulated in a muscle atrophy model, and its target protein was the myocyte enhancer factor 2C (MEF2C). miR-194 could promote muscle differentiation and also inhibit ubiquitin ligases, thus miR-194 could be used as a nucleic acid drug to treat muscle atrop...
Source
#1Keisuke Ueda (Chiba University)H-Index: 14
#2Kenjirou Higashi (Chiba University)H-Index: 22
Last. Kunikazu Moribe (Chiba University)H-Index: 28
view all 0 authors...
Cyclodextrin (CD) has been widely used as a solubilizing agent for poorly water-soluble drugs. In the present study, the effect of CD on the amorphous drug solubility and the maximum thermodynamic activity of the drug in the aqueous phase when the drug concentration exceeded the liquid-liquid phase separation (LLPS) concentration was investigated using three chemically diverse CDs, β-cyclodextrin (β-CD), dimethyl-β-CD (DM-β-CD), and hydroxypropyl-β-CD (HP-β-CD). The amorphous solubility of ibupr...
Source
#1Cristina Prieto (CSIC: Spanish National Research Council)H-Index: 8
#2Zoran Evtoski (CSIC: Spanish National Research Council)H-Index: 1
Last. Jose M. Lagaron (CSIC: Spanish National Research Council)H-Index: 71
view all 0 authors...
The high-throughput drying and encapsulation technique called electrospraying assisted by pressurized gas (EAPG) was used for the first time to produce nanostructured valsartan within microparticles of excipients. Valsartan, a poorly absorbed and lipid-soluble drug, was selected since it is considered a good model for BCS class II drugs. Two different polymeric matrices were selected as excipients, i.e., hydroxypropyl methylcellulose (HPMC) and lactose monohydrate, while Span 20 was used as a su...
Source
#2Piyush Gondaliya (Department of Biotechnology)H-Index: 9
Last. Kiran Kalia (Department of Biotechnology)H-Index: 24
view all 0 authors...
Cisplatin resistance is one of the major concerns in the treatment of oral squamous cell carcinoma (OSCC). Accumulating evidence suggests microRNA (miRNA) dysregulation as one of the mediators of chemoresistance. Toward this, our previous study revealed the role of exosomal microRNA-155 (miR-155) in cisplatin resistance via downregulation of FOXO3a, a direct target of miR-155, and induction of epithelial-to-mesenchymal transition in OSCC. In the present study, we demonstrate the therapeutic pote...
Source
#1Yash Kapoor (MSD: Merck & Co.)H-Index: 9
#2Robert F. Meyer (MSD: Merck & Co.)H-Index: 10
Last. Allen C. Templeton (MSD: Merck & Co.)H-Index: 14
view all 0 authors...
The process of bringing a drug to market involves innumerable decisions to refine a concept into a final product. The final product goes through extensive research and development to meet the target product profile and to obtain a product that is manufacturable at scale. Historically, this process often feels inflexible and linear, as ideas and development paths are eliminated early on to allow focus on the workstream with the highest probability of success. Carrying multiple options early in de...
Source
12345678910
Top fields of study
Molecular biology
Chemistry
In vivo
Drug delivery
Biochemistry
Pharmacology